Abstract: A blade outer air seal arc segment includes a ceramic matrix composite body that defines a core gaspath side, a non-core gaspath side opposite the core gaspath side, a forward end, an aft end, and circumferential sides. The ceramic matrix composite body has first and second flanges on the non-core gaspath side. The ceramic matrix composite body is comprised of fiber plies disposed in a ceramic matrix. The fiber plies include flange fiber plies that have a +/?15-75 degree ply layup arrangement.

Abstract: Antibodies specific for secretogranin III (Scg3) are disclosed. Methods of using the antibodies, antigen-binding fragments thereof, or pharmaceutical compositions comprising the same in the treatment of diseases such as diabetic retinopathy, neovascular age-related macular degeneration, retinopathy of prematurity, and cancer, are also disclosed.

Abstract: Antibodies specific for secretogranin III (Scg3) are disclosed. Methods of using the antibodies, antigen-binding fragments thereof, or pharmaceutical compositions comprising the same in the treatment of diseases such as diabetic retinopathy, neovascular age-related macular degeneration, retinopathy of prematurity, and cancer, are also disclosed.

Abstract: The present disclosure is drawn to oral cannabinoid compositions and methods for modulating inflammation in a subject. In some aspects, oral administration of an amount of a cannabinoid in a carrier to a subject reduces cytokine levels in the subject to a greater degree than an equivalent amount of the cannabinoid administered in an edible oil.

Abstract: Antibodies specific for secretogranin III (Scg3) are disclosed. Methods of using the antibodies, antigen-bin ding fragments thereof, or pharmaceutical compositions comprising the same in the treatment of diseases such as diabetic retinopathy, neovascular age-related macular degeneration, retinopathy of prematurity, and cancer, are also disclosed.

Abstract: In general, the invention relates to a method for transferring funds. The method includes receiving a request to initiate a secure fund transfer, where the request specifies a sender, a recipient, and an amount of funds to transfer from the sender to the recipient. The method further includes sending a request to verify that an account associated with the sender comprises at least the amount of funds to be transferred, receiving notification that the account comprises at least the amount of funds to be transferred, requesting a reservation of funds in the account corresponding to the amount of funds to be transferred, receiving notification of the reservation, notifying the recipient that the amount of funds to be transferred is reserved, initiating a transfer of funds, to the recipient, in the amount of the reserved funds, and receiving acknowledgment that the transfer of the funds is complete.

Abstract: A method for providing payroll services to an employer includes obtaining employee data for an employee of the employer, wherein the employee data is used by a payroll system, obtaining employer tax data of the employer, wherein the employer tax data is used by the payroll system, and managing a payroll and taxes of the employer using the payroll system, wherein managing the payroll of the employer comprises issuing a direct deposit paycheck by the payroll system based on the employee data and employer tax data, wherein managing the payroll of the employer and taxes of the employer is provided by the payroll system without cost to the employer.

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C1-C4 alkoxy group, or their precursor compounds, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to calm and/or reduce anxiety and related behaviors and states in humans and animals. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human and animal therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Abstract: A method of distributing pay includes obtaining payroll information associated with a payee, generating an electronic paycheck voucher based on the payroll information, wherein the electronic paycheck voucher is associated with a net pay of the payee, issuing the electronic paycheck voucher to the payee, and processing the electronic paycheck voucher to distribute the net pay based on a distribution preference defined by the payee.

Abstract: A spectacle assembly structured for use by individuals of different facial characteristics comprising a pair of lenses and a nose-bridge extending between the lens pair in interconnecting relation thereto. A nose pad assembly is connected to the nose-bridge and extends rearwardly thereof in supported engagement with a prominent nasal support on an individual's nose, wherein the location of the prominent nasal support is determined by the facial characteristics of the individual. The nose-bridge and the nose pad assembly are disposed in an operative position relative to the optical centers of the lens pair so as to facilitate substantial alignment between the optical centers and the pupils of the individual's eyes, when the nose pad assembly engages the prominent nasal support.

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C1-C4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C1-C4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding gluxosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C1-C4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C1-C4 alkoxy group, obtainable from monocotyledonous plants, or by chemicals synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, a nitrogen or another oxygen containing group, and a C1-C4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Abstract: A system that facilitates using information about a financial transaction to augment information in a representation of a social network. During operation, the system receives parameters for a financial transaction involving a number of entities. Next, the system determines one or more associations between the entities and the parameters. The system then uses the determined associations to augment information about entities in the representation of the social network.

Abstract: An isolated protein sequence or peptide from the E2, E6 or E7 early coding region of human papillomavirus (HPV) that is soluble in an aqueous medium, and characterized by a relative paucity of tryptophan, methionine and cysteine residues, and a relative abundance of glycine and asparagine residues. Also disclosed are isolated protein sequences or peptides from the E2, E6 or E7 early coding regions of HPV 16 and 18 and methodologies for detecting or diagnosing cancer or cellular abnormalities. Detection or diagnosis of Cancer or cellular abnormalities may include detecting or diagnosing pre-cancerous or pre-malignant conditions, cervical dysplasia, cervical carcinoma, koilocytosis, hyperkeratosis, intraepithelial lesions, and other cancers.

Abstract: An isolated protein sequence or peptide from the E2, E6 or E7 early coding region of human papillomavirus (HPV) that is soluble in an aqueous medium, and characterized by a relative paucity of tryptophan, methionine and cysteine residues, and a relative abundance of glycine and asparagine residues. Also disclosed are isolated protein sequences or peptides from the E2, E6 or E7 early coding regions of HPV 16 and 18 and methodologies for detecting or diagnosing cancer or cellular abnormalities. Detection or diagnosis of Cancer or cellular abnormalities may include detecting or diagnosing pre-cancerous or pre-malignant conditions, cervical dysplasia, cervical carcinoma, koilocytosis, hyperkeratosis, intraepithelial lesions, and other cancers.

Abstract: A system and method of deception detection is disclosed wherein T trials are combined with P and I trials. Denoted as the complex trial (CT) protocol, in one embodiment, the beginning of each trial is indicated by the onset of a stimulus which is either a P or I, which remains on the display terminal for particular random (unpredictable to the subject) time period. At the expiration of the period, the stimulus remains on the screen, but is altered/augmented in some way, such as by color change. The subject has been instructed that if the color change is to green, for example, the trial is a target trial, and the subject should make a “yes” (target) response. If the color is anything else (e.g., red, blue, yellow), the subject must give a “no” (non-target) response. Accordingly, in the CT protocol, the subject must attend even more intensely than in prior 3-stimulus protocols to the probe-irrelevant attribute (i.e.

Abstract: An isolated protein sequence or peptide from the E2, E6 or E7 early coding region of human papillomavirus (HPV) that is soluble in an aqueous medium, and characterized by a relative paucity of tryptophan, methionine and cysteine residues, and a relative abundance of glycine and asparagine residues. Also disclosed are isolated protein sequences or peptides from the E2, E6 or E7 early coding regions of HPV 16 and 18 and methodologies for detecting or diagnosing cancer or cellular abnormalities. Detection or diagnosis of Cancer or cellular abnormalities may include detecting or diagnosing pre-cancerous or pre-malignant conditions, cervical dysplasia, cervical carcinoma, koilocytosis, hyperkeratosis, intraepithelial lesions, and other cancers.